Compliance Program: Difference between revisions

Jump to navigation Jump to search
m
no edit summary
mNo edit summary
mNo edit summary
Line 17: Line 17:
</table>
</table>
<br />
<br />
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Trial Fee Billing Procedures]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International Research Policy]] | [[Health Care Vendor Interactions]] | [[Internal Audit]] | [[Credit Hour Definition]]
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International Research Policy]] | [[Health Care Vendor Interactions]] | [[Internal Audit]] | [[Credit Hour Definition]]
<br /><br />
<br /><br />
Policy No.: '''8000'''<br />
Policy No.: '''8000'''<br />
Line 70: Line 70:
*assist with understanding the compliance risks and related regulations and laws;  
*assist with understanding the compliance risks and related regulations and laws;  
*assist with response to alleged violation of rules, regulations, policies, procedures and other functions as needed to enforce this policy.<br />
*assist with response to alleged violation of rules, regulations, policies, procedures and other functions as needed to enforce this policy.<br />
<br />
 
Representatives would be from the following areas:  
Representatives would be from the following areas:  
*NU Director of Internal Audit
*NU Director of Internal Audit
Line 103: Line 103:
| Conflict of Interest || UNMC Policy No. 8010, [[Conflict of Interest]]
| Conflict of Interest || UNMC Policy No. 8010, [[Conflict of Interest]]
|-
|-
| Clinical Trial Billing || UNMC Policy No. 8008, [[Clinical Trial Fee Billing Procedures]]
| Clinical Trial Billing || UNMC Policy No. 8008, [[Clinical Trial Professional and Technical Fee Billing]]
|-
|-
| Research Integrity || UNMC Policy No. 8003, [[Research Integrity]]
| Research Integrity || UNMC Policy No. 8003, [[Research Integrity]]
Line 185: Line 185:
*UNMC Policy No. 2004, [[Bloodborne Pathogens Exposure]]
*UNMC Policy No. 2004, [[Bloodborne Pathogens Exposure]]
*UNMC Policy No. 6036, [[Reproducing Copyrighted Materials]]
*UNMC Policy No. 6036, [[Reproducing Copyrighted Materials]]
*UNMC Policy No. 6045, [[Privacy, Confidentiality and Information Security]] [https://www.unmc.edu/studentservices/ FERPA Information]  
*UNMC Policy No. 6045, [[Privacy, Confidentiality and Information Security]]  
*UNMC Policy No. 6051, [[Computer Use and Electronic Information Security]]
*UNMC Policy No. 6051, [[Computer Use and Electronic Information Security]]
*UNMC Policy No. 8001, [[Compliance Hotline]]
*UNMC Policy No. 8001, [[Compliance Hotline]]
Line 191: Line 191:
*UNMC Policy No. 8006, [[Code of Conduct]]  
*UNMC Policy No. 8006, [[Code of Conduct]]  
*UNMC Policy No. 8010, [[Conflict of Interest]]
*UNMC Policy No. 8010, [[Conflict of Interest]]
*[https://www.unmc.edu/studentservices/ FERPA Information]
<br />
<br />


This page maintained by [mailto:dpanowic@unmc.edu dkp].
This page maintained by [mailto:dpanowic@unmc.edu dkp].

Navigation menu